EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Novel 14-Gene Panel Associated With Efferocytosis for Predicting Pancreatic Cancer Prognosis Through Bulk and Single-Cell Databases

Yaheng Wu, Lin Zhao, Dingyan Yi, Zhihua Tian, Bin Dong, Chunxiang Ye, Jingtao Liu, Huachong Ma, Wei Zhao

Frontiers in Bioscience-Landmark · 2025

DOI: 10.31083/fbl40818 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Bioscience-Landmark, 2025. Verfasst von Yaheng Wu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Medicine, Beijing Luhe Hospital, Capital Medical University, 101149 Beijing, China. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal, Phagocytosis, Biomarkers, Tumor. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Noncommunicable Chronic Diseases-National Science and Technology Major Project, National Natural Science Foundation of China, Foundation of China Association for Promotion of Health Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Efferocytosis (ER) plays a crucial role in the programmed clearance of dead cells, a process that is mediated by phagocytic immune cells. However, further exploration is needed to determine the full extent of its impact on the progression of pancreatic ductal adenocarcinoma (PDAC), particularly through interactions among tumor cells, stromal cells, and immune cells within the tumor microenvironment (TME). Methodology and Results: In this study, we comprehensively analyzed the Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) database, as well as additional databases from multiple bioinformatics websites, utilizing 167 ER features derived from the integration of single-cell RNA sequencing (scRNA-seq) and bulk transcriptomic data. A set of 14 ER-associated prognostic signatures, referred to as the “14-gene panel” genes, was identified based on overall survival (OS)/disease-free survival (DFS) data, Pearson correlation coefficients, and multivariate Cox regression analyses. The model pathways enriched by the four-gene combination represented by “LEAF” and the 14-gene combination represented by the “14-gene panel” presented a high degree of similarity, including among the adhesion, mitotic, G2/M checkpoint, and epithelial‒mesenchymal transition (EMT) signaling pathways. Least absolute shrinkage and selection operator (LASSO) regression was subsequently employed to construct an ER risk scoring system using deep learning, based on the following formula: LGALS3, EMP1, ASPH, and FNDC3B, collectively termed the “LEAF” panel. Additionally, random survival forest (RSF) algorithms facilitated the identification of a key panel of genes, designated “LEAP” genes, including LGALS3, EREG, ASPH, and PLS3; three of which genes (ASPH, LGALS3, and EREG) were identified as key factors influencing the behaviors of PDAC tumors, tumor-associated stroma, and macrophages. Finally, we utilized experimental methods, including Boyden chamber analyses, immunohistochemical staining, and cell cycle analyses, to demonstrate that interference with ASPH suppresses the malignant properties of tumors, including proliferation and migration. Multiplex immunofluorescence staining was employed to identify EREG as highly relevant to the M2 macrophage subpopulation.

Conclusion

Our findings underscore the importance of considering a novel prognostic signature comprising 14 ER genes in the context of the TME when investigating the biology of PDAC. Future studies may explore how modulating these interactions could lead to novel therapeutic opportunities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsCarcinoma, Pancreatic DuctalPhagocytosisBiomarkers, TumorHumansPrognosisTumor MicroenvironmentSingle-Cell AnalysisGene Expression Regulation, NeoplasticDatabases, GeneticGene Expression ProfilingTranscriptomeEfferocytosis

Stichwörter der Autor:innen

efferocytosispancreatic ductal adenocarcinomaprognosistumor microenvironment

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Clinical Medicine, Beijing Luhe Hospital, Capital Medical University, 101149 Beijing, China.
  • Key Laboratory of Carcinogenesis and Translational Research, Department of Thoracic Surgery II, Peking University Cancer Hospital & Institute, 100142 Beijing, China.
  • College of Chemistry and Life Science, Beijing University of Technology, 100029 Beijing, China.
  • Key Laboratory of Carcinogenesis and Translational Research, Department of Central Laboratory, Peking University Cancer Hospital & Institute, 100142 Beijing, China.
  • Department of General Surgery, Beijing Chaoyang Hospital, Capital Medical University, 100020 Beijing, China.
  • Key Laboratory of Carcinogenesis and Translational Research, Department of Pharmacology, Peking University Cancer Hospital & Institute, 100142 Beijing, China.

Förderung

  • Noncommunicable Chronic Diseases-National Science and Technology Major Project
  • National Natural Science Foundation of China
  • Foundation of China Association for Promotion of Health Science and Technology
  • Science Foundation of Peking University Cancer Hospital

Zitieren

APA

Wu, Y., Zhao, L., Yi, D., Tian, Z., Dong, B., Ye, C., Liu, J., Ma, H., & Zhao, W. (2025). A Novel 14-Gene Panel Associated With Efferocytosis for Predicting Pancreatic Cancer Prognosis Through Bulk and Single-Cell Databases. Frontiers in Bioscience-Landmark. https://doi.org/10.31083/fbl40818

Vancouver

Wu Y, Zhao L, Yi D, Tian Z, Dong B, Ye C, et al. A Novel 14-Gene Panel Associated With Efferocytosis for Predicting Pancreatic Cancer Prognosis Through Bulk and Single-Cell Databases. Frontiers in Bioscience-Landmark. 2025. doi:10.31083/fbl40818

BibTeX
@article{Wu2025,
  author = {Wu, Yaheng and Zhao, Lin and Yi, Dingyan and Tian, Zhihua and Dong, Bin and Ye, Chunxiang and Liu, Jingtao and Ma, Huachong and Zhao, Wei},
  title = {A Novel 14-Gene Panel Associated With Efferocytosis for Predicting Pancreatic Cancer Prognosis Through Bulk and Single-Cell Databases},
  journal = {Frontiers in Bioscience-Landmark},
  year = {2025},
  doi = {10.31083/fbl40818}
}
Kostenlos starten →